publication venue for
- Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy.. 32:200906. 2024
- Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling. 32:200842-200842. 2024
- Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer. 31:100748-100748. 2023
- IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity. 25:16-30. 2022
- A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity. 17:278-292. 2020
- Infectious Optimism following the 10th International Oncolytic Virus Meeting. 7:12-16. 2017
- Chimeric antigen receptor–engineered T cells as oncolytic virus carriers. 2:15014-15014. 2015
- Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma. 2:15004-15004. 2015